The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Antibiotic Resistance Global Market Report 2023, The global antibiotic resistance market is expected to grow from $10.7 billion in 2022 to $11.43 billion in 2023 at a compound annual growth rate (CAGR) of 6.8%. The antibiotic resistance market is expected to reach $14.4 billion in 2027 at a CAGR of 5.9%.

What was the major driver in the antibiotic resistance market?
The prevalence of drug-resistant infections is expected to propel the growth of the antibiotic-resistance market going forward. Drug-resistant infections are diseases caused by resistant bacteria, resulting in an infection that is far more difficult or impossible to cure. Antimicrobial resistance drugs help treat various drug-resistant infections with improved antibiotic treatment outcomes concerning both target and nontarget pathogens, dependent on the details of resistance mechanisms and microbiome community interaction structure. For instance, in November 2022, according to the European Centre for Disease Prevention and Control, a Sweden-based European Union agency for public health, around 35 000 persons in the EU/EEA die each year from antimicrobial-resistant diseases. Moreover, Klebsiella pneumoniae infections increased by 31% in 2020, and another 20% in 2021, and the number of Candida auris reported cases virtually doubled between 2020 and 2021. Therefore, the prevalence of drug resistance infection is driving the antibiotic resistance market.

View More On The Antibiotic Resistance Market Report 2023 – https://www.thebusinessresearchcompany.com/report/antibiotic-resistance-global-market-report

What was the key trend in the antibiotic resistance market?
Product innovations are the key trend gaining popularity in the antibiotic resistance market. Major companies operating in the antibiotic resistance market are focused on developing innovative products to strengthen their position in the market. For instance, in January 2023, Alkem Laboratories Limited, an India-based pharmaceutical company, introduced Zidavi, a novel antibiotic for multi-drug resistant (MDR) infections, to ensure availability, affordability, and accessibility while saving the lives of critically ill patients. Zidavi is a unique combination of ceftazidime and avibactam that can treat infections caused by multi-drug resistant (MDR) gram-negative pathogens. It is available for infusion in sterile powdered concentrate for reconstitution, comprising ceftazidime pentahydrate equivalent to 2 g ceftazidime and avibactam sodium equivalent to 0.5 g avibactam in each single-dose vial. Also, it offers an effective alternative to treat hospital-acquired pneumonia (HAP) and severe intra-abdominal infections (IAIs) caused by meropenem and colistin.

Which was the largest region in the antibiotic resistance market?
North America was the largest region in the antibiotic resistance market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antibiotic resistance report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the antibiotic resistance market prominent players?
Major players in the antibiotic resistance market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd, AbbVie Inc., Novartis AG, Merck and Co. Inc., Bristol-Myers Squibb, Sanofi S.A., Thermo Fisher Scientific Inc, AstraZeneca, GlaxoSmithKline Plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Astellas Pharma, Daiichi Sankyo, Chugai Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Bio-Rad Laboratories Inc, Eppendorf Corporation, Takara Bio Inc, Wockhardt Ltd., Paratek Pharmaceuticals Inc., Basilea Pharmaceutica Ltd., Theravance Biopharma Inc., Nabriva Therapeutics Plc, Seres Therapeutics Inc, and Armata Pharmaceuticals Inc.

Key antibiotic resistance market segments
The global antibiotic resistance market is segmented –
1) By Drug Class: Beta Lactum Antibiotic, Cephalosporins, Quinolones Antibiotics, Macrolide Antibiotics, Tetracyclines, Oxazolidinones, Other Drug Classes
2) By Pathogen: Staphylococcus aureus, Staphylococcus pneumonia, Neisseria gonorrhoeae, Enterococcus Faecium, Escherichia coli, Klebsiella pneumonia, Shigella, Clostridium difficile, Other pathogens
3) By Disease Type: Urinary tract infection, Intra-abdominal infection, Blood stream infections, Clostridium difficile infections, Other Disease Types
4) By Mechanism of Action: Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Other Mechanism Of Actions
5) By End Users: Hospitals, Homecare, Specialty clinics, Other End-users

Request A Sample Of The Global Antibiotic Resistance Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12131&type=smp

The Antibiotic Resistance Global Market Report 2023  provides a comprehensive overview on the antibiotic resistance market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Antibiotics Global Market Report 2023
Genetically Modified Crops Global Market Report 2023
GMO Testing Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model